| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 11.13× | 11.13× | 10.68× | 8.80× | 7.54× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.43× | 0.43× | 0.44× | 0.43× | 0.47× | ||
| 0.83× | 0.83× | 0.76× | 0.88× | 0.73× | ||
| 0.73× | 0.73× | 0.72× | 0.90× | 0.62× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 7.54 | 8.80 | 10.68 | 11.13 | 11.13 | |
| Asset Turnover | 0.47 | 0.43 | 0.44 | 0.43 | 0.43 | |
| Cash Conversion (CFO/Net Income) | 0.73 | 0.88 | 0.76 | 0.83 | 0.83 | |
| CFO/EBITDA | 0.62 | 0.90 | 0.72 | 0.73 | 0.73 |